Jane Street
BDR

Jane Street’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Jane Street’s Portfolio BDR Stock Details BDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,124
Closed -$13K – 5999
2018
Q3 		$13K Buy
+10,124
New +$13.1K ﹤0.01% 4988

Other funds holding BDR

BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $5.76B AUM 24.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Jane Street's BDR Position: Q4 2018 in Review

Jane Street sold out of Blonder Tongue Laboratories Inc (BDR) in Q4 2018, closing a stake of 10,124 shares — an estimated $13K sold.

Jane Street first reported a position in BDR in Q3 2018 and held it in 1 quarter. The position peaked at $13K in Q3 2018. 8 funds tracked by Wall St. Rank hold BDR as of Q4 2018.

  • Jane Street reported no remaining Blonder Tongue Laboratories Inc position as of Q4 2018 after selling out during the quarter.
  • Jane Street sold 10,124 Blonder Tongue Laboratories Inc shares in Q4 2018, an estimated $13K.
  • Jane Street first reported a position in Blonder Tongue Laboratories Inc in Q3 2018 and held it in 1 quarter.
  • Jane Street's Blonder Tongue Laboratories Inc position peaked at $13K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q4 2018.

Based on Jane Street's 13F filing for Q4 2018, filed 15 Feb 2019.